Cargando…

Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic

Detalles Bibliográficos
Autores principales:	Kleideiter, Elke, Piana, Chiara, Wang, Shaonan, Nemeth, Robert, Gautrois, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028882/ https://www.ncbi.nlm.nih.gov/pubmed/29949019 http://dx.doi.org/10.1007/s40262-018-0686-x

Ejemplares similares

Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
por: Kleideiter, Elke, et al.
Publicado: (2017)

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study
por: Göhler, Karin, et al.
Publicado: (2019)

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial
por: Christoph, Annette, et al.
Publicado: (2017)

Cebranopadol: A First-in-Class Nociceptin Receptor Agonist for Managing Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2020)

A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism
por: Fantinati, Anna, et al.
Publicado: (2017)

Effects of Cebranopadol on Cocaine-induced Hyperactivity and Cocaine Pharmacokinetics in Rats
por: Wei, Huimei, et al.
Publicado: (2020)

Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist
por: Rizzi, Anna, et al.
Publicado: (2016)

Cebranopadol as a Novel Promising Agent for the Treatment of Pain
por: Ziemichod, Wojciech, et al.
Publicado: (2022)

Correction: Discovery and clinical introduction of first-in-class imipridone ONC201
por: Allen, Joshua E., et al.
Publicado: (2021)

Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model
por: Christoph, Thomas, et al.
Publicado: (2018)

Correction: Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha
Publicado: (2015)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor
por: James, Angela Joubert, et al.
Publicado: (2021)

Correction to: Classes of tree-based networks
por: Fischer, Mareike, et al.
Publicado: (2021)

Correction to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children
por: Boonsathorn, Sophida, et al.
Publicado: (2018)

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study
por: Na, Joo Young, et al.
Publicado: (2022)

Correction to: Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
por: Li, Yan, et al.
Publicado: (2021)

Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
por: Sałat, Kinga, et al.
Publicado: (2017)

Correction: HLA Class I and Class II Associations with ESRD in Saudi Arabian Population
por: Hamdi, Nuha Mahmoud, et al.
Publicado: (2017)

Correction: Latent class analysis of IPOs in the Nordics
Publicado: (2023)

Correction to: Analgesic Effects of Navigated Repetitive Transcranial Magnetic Stimulation in Patients With Acute Central Poststroke Pain
por: Zhao, Chen-Guang, et al.
Publicado: (2021)

Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
Publicado: (2021)

Correction to: Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis
por: Guo, Kai-Kai, et al.
Publicado: (2018)

Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
por: Festuccia, C., et al.
Publicado: (2018)

Correction: Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
Publicado: (2014)

Correction to: the impact of pharmacokinetic gene profiles across human cancers
por: Zimmermann, Michael T., et al.
Publicado: (2018)

Correction: Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling
por: Ando, Hirotaka, et al.
Publicado: (2009)

Correction: Correction: Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion
Publicado: (2017)

Correction: Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) Prolong Analgesic Effect of a Preoperative Interscalene Block
por: Noor, Nazir A, et al.
Publicado: (2020)

Correction to: Patterns and predictors of analgesic use in pregnancy: a longitudinal drug utilization study with special focus on women with migraine
por: Harris, Gerd-Marie Eskerud, et al.
Publicado: (2022)

Author Correction: Evaluating analgesic efficacy and administration route following craniotomy in mice using the grimace scale
por: Cho, Chulmin, et al.
Publicado: (2019)

Correction: Rapid Pharmacokinetic and Biodistribution Studies Using Chlorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method
por: Lee, Michelle Jeung-Eun, et al.
Publicado: (2010)

Correction: Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method
por: Lee, Michelle Jeung-Eun, et al.
Publicado: (2010)

Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
por: Conlan, Maureen G., et al.
Publicado: (2020)

Correction: Equivalent Indels – Ambiguous Functional Classes and Redundancy in Databases
por: Assmus, Jens, et al.
Publicado: (2013)

Correction: Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays
por: Noor, Zainab, et al.
Publicado: (2015)

Correction: Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion
Publicado: (2016)

Correction to: Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use
por: Wilkinson, Vicky, et al.
Publicado: (2021)

Correction: Pharmacokinetics of Natural and Engineered Secreted Factors Delivered by Mesenchymal Stromal Cells
Publicado: (2014)

Correction: In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uorssljvf3ml9dn2a7ftvlm9kp